Lataa...
ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy
BACKGROUND: Possible targeted therapies for metastatic triple negative breast cancer (TNBC) include cytotoxic chemotherapy that causes interstrand breaks (platinum-based drugs). The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathw...
Tallennettuna:
| Julkaisussa: | Asian Pac J Cancer Prev |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
West Asia Organization for Cancer Prevention
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5454751/ https://ncbi.nlm.nih.gov/pubmed/28345838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.2.507 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|